BCTX logo

BriaCell Therapeutics (BCTX) Selling, General & Administrative Expenses

Annual SGA

$6.15 M
-$1.78 M-22.47%

July 31, 2024

Summary

Performance

1-Year Change

-22.47%

3-Year Change

+24.16%

5-Year Change

+487.56%

15-Year Change

+602.16%

BCTX SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

11.99%
BCTX annual SGA is higher than 11.99% of companies in Healthcare sector

High & Low

All-time High

$7.94 M
BCTX annual SGA is currently -22.47% below its historical high of $7.94 million

3-Year Low

$4.96 M
BCTX annual SGA is currently +24.16% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Jul 31, 2024
BCTX previous annual earnings announcement was published on Jul 31, 2024

Next Annual Earnings Report Date

N/A
BCTX next annual earnings announcement has not yet been scheduled

OtherBCTXexpensesmetrics:

Annual Total Expenses

$33.33 M
BCTX annual total expenses is $33.33 million

Annual Operating Expenses

$33.33 M
BCTX annual total operating expenses is $33.33 million

Annual Cost Of Goods Sold

-
BCTX annual cost of goods sold value is unknown

Annual Interest Expense

-
BCTX annual interest expense value is unknown

Quarterly SGA

$1.49 M
+$125.00 K+9.17%

October 31, 2024

Summary

Performance

3-Month Change

+9.17%

1-Year Change

-5.38%

3-Year Change

-23.27%

5-Year Change

-23.27%

BCTX Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

11.44%
BCTX quarterly SGA is higher than 11.44% of companies in Healthcare sector

High & Low

All-time High

$3.68 M
BCTX quarterly SGA is currently -59.55% below its historical high of $3.68 million

3-Year Low

$1.36 M
BCTX quarterly SGA is currently +9.17% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Oct 31, 2024
BCTX previous earnings announcement was published on Oct 31, 2024

Next Quarterly Earnings Report Date

Mar 18, 2025
BCTX next earnings announcement is scheduled for Mar 18, 2025

OtherBCTXexpensesmetrics:

Quarterly Total Expenses

$5.15 M
BCTX quarterly total expenses is $5.15 million

Quarterly Operating Expenses

$5.15 M
BCTX quarterly total operating expenses is $5.15 million

Quarterly Cost Of Goods Sold

-
BCTX quarterly cost of goods sold value is unknown

Quarterly Interest Expense

-
BCTX quarterly interest expense value is unknown

TTM SGA

-$346.86 M
-$16.60 M-5.02%

October 31, 2024

Summary

Performance

3-Month Change

-5737.96%

1-Year Change

-4833.35%

3-Year Change

-4406.36%

5-Year Change

-4406.36%

BCTX TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

68.4%
BCTX TTM SGA is higher than 68.4% of companies in Healthcare sector

High & Low

All-time High

-$37.20 K

3-Year Low

-$346.86 M
BCTX TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Oct 31, 2024
BCTX previous earnings announcement was published on Oct 31, 2024

Next Quarterly Earnings Report Date

Mar 18, 2025
BCTX next earnings announcement is scheduled for Mar 18, 2025

OtherBCTXexpensesmetrics:

Annual Total Expenses

$33.33 M
BCTX annual total expenses is $33.33 million

Annual Operating Expenses

$33.33 M
BCTX annual total operating expenses is $33.33 million

TTM Cost Of Goods Sold

-
BCTX TTM cost of goods sold value is unknown

TTM Interest Expense

-
BCTX TTM interest expense value is unknown

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$6.15 M
BCTX annual SGA is $6.15 million

Annual Operating Expenses

$33.33 M
BCTX annual total operating expenses is $33.33 million

Annual Cost Of Goods Sold

-
BCTX annual cost of goods sold value is unknown

BCTX Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-22.5%-5.4%-4833.4%
3 y3 years+24.2%-23.3%-4406.4%
5 y5 years+487.6%-23.3%-4406.4%

BCTX Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-22.5%+24.2%-41.4%+9.2%-312.7%at low
5 y5-year-22.5%+487.6%-59.5%+7086.0%-501.8%at low
alltimeall time-22.5%>+9999.0%-59.5%+444.0%<-9999.0%at low

BriaCell Therapeutics Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Oct 2024
-
$1.49 M(+9.2%)
$5.99 M(-2.6%)
Jul 2024
$6.15 M(-22.5%)
$1.36 M(-13.3%)
$6.15 M(-16.0%)
Apr 2024
-
$1.57 M(0.0%)
$7.33 M(-3.2%)
Jan 2024
-
$1.57 M(-4.5%)
$7.57 M(+1.9%)
Oct 2023
-
$1.65 M(-35.2%)
$7.43 M(-6.3%)
Jul 2023
$7.94 M(+9.2%)
$2.54 M(+39.7%)
$7.94 M(+6.3%)
Apr 2023
-
$1.82 M(+26.8%)
$7.46 M(-0.5%)
Jan 2023
-
$1.43 M(-33.3%)
$7.50 M(-6.3%)
Oct 2022
-
$2.15 M(+4.0%)
$8.01 M(+10.2%)
Jul 2022
$7.27 M(+46.7%)
$2.07 M(+11.4%)
$7.27 M(+16.6%)
Apr 2022
-
$1.85 M(-4.3%)
$6.23 M(-22.6%)
Jan 2022
-
$1.94 M(+37.6%)
$8.05 M(+31.3%)
Oct 2021
-
$1.41 M(+36.9%)
$6.14 M(+23.8%)
Jul 2021
$4.96 M(+230.7%)
$1.03 M(-72.0%)
$4.96 M(+16.5%)
Apr 2021
-
$3.68 M(>+9900.0%)
$4.26 M(+387.6%)
Jan 2021
-
$20.70 K(-90.9%)
$872.70 K(-35.4%)
Oct 2020
-
$227.50 K(-31.0%)
$1.35 M(-12.2%)
Jul 2020
$1.50 M(+43.1%)
$329.50 K(+11.7%)
$1.54 M(-3.4%)
Apr 2020
-
$295.00 K(-40.8%)
$1.59 M(-1.8%)
Jan 2020
-
$497.90 K(+20.2%)
$1.62 M(+25.0%)
Oct 2019
-
$414.30 K(+8.2%)
$1.29 M(+17.7%)
Jul 2019
$1.05 M(-26.1%)
$382.80 K(+18.2%)
$1.10 M(-10.4%)
Apr 2019
-
$323.80 K(+86.1%)
$1.23 M(-17.8%)
Jan 2019
-
$174.00 K(-20.7%)
$1.49 M(-0.8%)
Oct 2018
-
$219.50 K(-57.0%)
$1.51 M(+5.7%)
Jul 2018
$1.42 M(+61.8%)
$510.60 K(-13.4%)
$1.43 M(+18.3%)
Apr 2018
-
$589.50 K(+216.3%)
$1.20 M(+32.5%)
Jan 2018
-
$186.40 K(+34.5%)
$908.80 K(+1.4%)
Oct 2017
-
$138.60 K(-52.2%)
$896.40 K(+1.3%)
Jul 2017
$876.20 K(-7.0%)
$289.80 K(-1.4%)
$885.20 K(+443.1%)
Apr 2017
-
$294.00 K(+69.0%)
$163.00 K(+35.3%)
Jan 2017
-
$174.00 K(+36.6%)
$120.50 K(-78.9%)
Oct 2016
-
$127.40 K(-129.5%)
$571.10 K(-5.7%)
Jul 2016
$942.00 K(-13.0%)
-$432.40 K(-271.9%)
$605.80 K(-42.8%)
Apr 2016
-
$251.50 K(-59.7%)
$1.06 M(-9.5%)
Jan 2016
-
$624.60 K(+285.3%)
$1.17 M(+1.2%)
Oct 2015
-
$162.10 K(+647.0%)
$1.16 M(+10.2%)
DateAnnualQuarterlyTTM
Jul 2015
$1.08 M(+270.9%)
$21.70 K(-94.0%)
$1.05 M(-8.4%)
Apr 2015
-
$363.20 K(-40.5%)
$1.15 M(+35.7%)
Jan 2015
-
$610.50 K(+1010.0%)
$844.40 K(+189.5%)
Oct 2014
-
$55.00 K(-53.2%)
$291.70 K(-0.5%)
Jul 2014
$291.90 K(-0.6%)
$117.50 K(+91.4%)
$293.30 K(+18.9%)
Apr 2014
-
$61.40 K(+6.2%)
$246.60 K(-5.6%)
Jan 2014
-
$57.80 K(+2.1%)
$261.20 K(-5.8%)
Oct 2013
-
$56.60 K(-20.1%)
$277.20 K(-6.1%)
Jul 2013
$293.80 K(-25.6%)
$70.80 K(-6.8%)
$295.30 K(-1.7%)
Apr 2013
-
$76.00 K(+3.0%)
$300.50 K(-3.9%)
Jan 2013
-
$73.80 K(-1.2%)
$312.80 K(-10.4%)
Oct 2012
-
$74.70 K(-1.7%)
$349.00 K(-17.6%)
Jul 2012
$395.00 K(-62.4%)
$76.00 K(-13.9%)
$423.70 K(-50.5%)
Apr 2012
-
$88.30 K(-19.7%)
$856.10 K(-14.8%)
Jan 2012
-
$110.00 K(-26.4%)
$1.00 M(-6.9%)
Oct 2011
-
$149.40 K(-70.6%)
$1.08 M(+4.1%)
Jul 2011
$1.05 M(+225.3%)
$508.40 K(+114.8%)
$1.04 M(+82.3%)
Apr 2011
-
$236.70 K(+28.4%)
$568.70 K(+14.0%)
Jan 2011
-
$184.40 K(+72.0%)
$498.70 K(+36.2%)
Oct 2010
-
$107.20 K(+165.3%)
$366.10 K(+15.9%)
Jul 2010
$323.30 K(+38.3%)
$40.40 K(-75.8%)
$315.80 K(-24.0%)
Apr 2010
-
$166.70 K(+221.8%)
$415.70 K(+61.2%)
Jan 2010
-
$51.80 K(-9.0%)
$257.90 K(+7.4%)
Oct 2009
-
$56.90 K(-59.4%)
$240.20 K(+2.0%)
Jul 2009
$233.70 K(+104.8%)
$140.30 K(+1476.4%)
$235.50 K(+55.0%)
Apr 2009
-
$8900.00(-73.9%)
$151.90 K(-11.3%)
Jan 2009
-
$34.10 K(-34.7%)
$171.30 K(+9.3%)
Oct 2008
-
$52.20 K(-7.9%)
$156.70 K(+36.5%)
Jul 2008
$114.10 K(-11.6%)
$56.70 K(+100.4%)
$114.80 K(+17.7%)
Apr 2008
-
$28.30 K(+45.1%)
$97.50 K(+18.6%)
Jan 2008
-
$19.50 K(+89.3%)
$82.20 K(-23.6%)
Oct 2007
-
$10.30 K(-73.9%)
$107.60 K(-14.5%)
Jul 2007
$129.10 K(+1401.2%)
$39.40 K(+203.1%)
$125.80 K(+45.6%)
Apr 2007
-
$13.00 K(-71.0%)
$86.40 K(+17.7%)
Jan 2007
-
$44.90 K(+57.5%)
$73.40 K(+157.5%)
Oct 2006
-
$28.50 K
$28.50 K
Jul 2006
$8600.00
-
-

FAQ

  • What is BriaCell Therapeutics annual SGA?
  • What is the all time high annual SGA for BriaCell Therapeutics?
  • What is BriaCell Therapeutics annual SGA year-on-year change?
  • What is BriaCell Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for BriaCell Therapeutics?
  • What is BriaCell Therapeutics quarterly SGA year-on-year change?
  • What is BriaCell Therapeutics TTM SGA?
  • What is the all time high TTM SGA for BriaCell Therapeutics?
  • What is BriaCell Therapeutics TTM SGA year-on-year change?

What is BriaCell Therapeutics annual SGA?

The current annual SGA of BCTX is $6.15 M

What is the all time high annual SGA for BriaCell Therapeutics?

BriaCell Therapeutics all-time high annual SGA is $7.94 M

What is BriaCell Therapeutics annual SGA year-on-year change?

Over the past year, BCTX annual SGA has changed by -$1.78 M (-22.47%)

What is BriaCell Therapeutics quarterly SGA?

The current quarterly SGA of BCTX is $1.49 M

What is the all time high quarterly SGA for BriaCell Therapeutics?

BriaCell Therapeutics all-time high quarterly SGA is $3.68 M

What is BriaCell Therapeutics quarterly SGA year-on-year change?

Over the past year, BCTX quarterly SGA has changed by -$84.50 K (-5.38%)

What is BriaCell Therapeutics TTM SGA?

The current TTM SGA of BCTX is -$346.86 M

What is the all time high TTM SGA for BriaCell Therapeutics?

BriaCell Therapeutics all-time high TTM SGA is -$37.20 K

What is BriaCell Therapeutics TTM SGA year-on-year change?

Over the past year, BCTX TTM SGA has changed by -$354.19 M (-4833.35%)